Knoxville Personal Injury Lawyer
Placeholder Groupshot Groupshot Groupshot Bruce D. Fox Attorney Attorney Groupshot Attorney Attorney Attorney Attorneys Attorney Groupshot Groupshot Attorney and Award-Winning Dog

We change people's lives in Greater Knoxville and Statewide

Knoxville Personal Injury Lawyer > Tennessee Uloric Lawyer

Tennessee Uloric Lawyer

Over the past two decades gout–a complex form of arthritis–has seen a resurgence in the United States. Gout is the result of excess uric acid in the bloodstream that forms crystals in a person’s joints, causing significant pain. The modern increase in gout cases is commonly attributed to poor diet and obesity, and the disease is more common in men than women.

Uloric, the branded name for the drug febuxostat, is a prescription medication used to treat gout. Specifically, Uloric is designed to reduce the levels of uric acid. Takeda Pharmaceutical Company, Uloric’s manufacturer, has sold an estimated 1.3 million prescriptions for the drug between 2012 and 2017.

But Uloric carries potentially deadly side effects. In June 2018, the consumer advocacy group Public Citizen filed a petition asking the FDA to remove Uloric from the market due to the increased “risk of death” compared to alternative gout treatments. And thanks to a recent “whistleblower” claim by a former Takeda employee, there is evidence that suggests the manufacturer altered internal reports regarding the potential complications from using the drug.

If you have taken Uloric–or lost a family member who was using the drug–you may have a claim for damages against Takeda. A qualified Tennessee lawyer can review your case and advise you on the proper steps to take next.

Takeda Under Fire for Downplaying Heart Attack, Stroke Risks

The Takeda whistleblower filed a lawsuit in federal court accusing the pharmaceutical company of pressuring her to “falsify medical conclusions” related to Uloric and other drugs and reclassify her assessment of certain adverse events in order to avoid triggering a mandatory FDA reporting deadline. In its own filing with the FDA, Public Citizen noted there was “overwhelming evidence that the serious cardiovascular harms of febuxostat outweigh any purported clinical benefit” for gout patients.

Indeed, in November 2017 the FDA issued its own alert confirming there was an “increased risk of heart-related death” due to heart attack and stroke for patients taking Uloric versus other approved gout medications. Although the FDA has yet to order Uloric taken off the market, the agency ordered Takeda to perform additional safety studies.

It should be noted it took Takeda three chances to obtain the initial approval for Uloric. Early clinical trials of the drug’s safety clearly revealed the existence of “adverse events” that were not seen in subjects assigned a placebo or allopurinol, another commonly prescribed gout drug.

A Tennessee Uloric Attorney Can Help You

Aside from the increased risk of heart attack and stroke, Takeda warns that Uloric may cause other serious side effects, including gout flares, liver problems, and severe skin and allergic reactions.

If you or a loved one have experienced any of these side effects, you need to explore your legal options with an experienced Tennessee Uloric lawyer. At Fox & Farley, we specialize in complex dangerous and defective drug litigation. Call us at 866-862-4855 or contact us online to schedule a free, no-obligation consultation with a member of our legal team today.

Share This Page:
Facebook Twitter LinkedIn Google Plus
MileMark Media - Practice Growth Solutions

© 2017 Fox & Farley, Attorneys at Law. All rights reserved.
This law firm website is managed by MileMark Media.

Contact Form Tab